Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes &amp; Diseases 9 (2022) 466–478]

Chunmei Yang; Lulu Zhang; Huakun Huang; Xiaohui Yuan; Ping Zhang; Caihong Ye; Mengqi Wei; Yanran Huang; Xiaoji Luo; Jinyong Luo

doi:10.1016/j.gendis.2023.02.002

您当前的位置：

首页 >

文章列表页 >

Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]

Erratum | 更新时间：2023-05-16

- Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]
- Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]
- Genes & Diseases 2023年10卷第2期
- 作者机构：
  
  1. School of Laboratory Medicine, Chongqing Medical University,Chongqing,China,400016
  2. Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400042
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.02.002
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-3-1，
扫描看全文
Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478][J]. Genes & Diseases, 2023,10(2).

Chunmei Yang, Lulu Zhang, Huakun Huang, et al. Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478][J]. Genes & Diseases, 2023,10(2).
Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478][J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.gendis.2023.02.002.

Chunmei Yang, Lulu Zhang, Huakun Huang, et al. Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478][J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.gendis.2023.02.002.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]

Corrigendum to ‘Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways’ [Genes & Diseases 9 (2022) 466–478]

DOI：10.1016/j.gendis.2023.02.002

摘要

Abstract

关键词

Keywords

references